Back

Cost-effectiveness of secondary prevention

11 April 2019 (14:45 - 15:07)
Organised by:
Congress Presentation Part of: Cardiovascular prevention: is it worth the money? Public Health and Health Economics EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Ms Gemma E Shields

Manchester (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
The economic burden of cardiovascular disease.
Professor F. Pinto (Lisbon, PT)
Slides Video
Presentation thumbnail
Cost-effectiveness of primary prevention.
Professor O. Franco Duran (Bern, CH)
Slides Video
Presentation thumbnail
Cost-effectiveness of telerehabilitation
Doctor I. Frederix (Heerlen, NL)
Slides Video

Access the full session

Session thumbnail
Cardiovascular prevention: is it worth the money?

The Event

Event poster

EuroPrevent 2019

11 April 2019 14:45 CET
You may be interested in
thumbnail
Congress Session
Evolutions in arrythmia and syncope management
thumbnail
Congress Presentation
Cost-effectiveness of HerzMobil Tirol, a multidimensional post-discharge disease management program for heart failure patients Economic evaluation along a one-year observation period
thumbnail
Congress Presentation
Newcard telemonitoring system improves survival at a lower cost than traditional approaches in chronic heart failure patients as assessed by data extract from the French National Health Data System

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources